Steroidal 21-imidazolium salt derivatives: Synthesis and anticancer activity
Author:
Sucman Natalia S.ORCID,
Ya. Bilan DmitriORCID,
Cojocari Sergiu V.ORCID,
Pogrebnoi Vsevolod S.ORCID,
Stîngaci Eugenia P.ORCID,
Khripach Vladimir A.ORCID,
Zhabinskii Vladimir N.ORCID,
Tsybruk Tatsiana V.ORCID,
Grabovec Irina P.,
Panibrat Olesya V.ORCID,
Persoons Leentje,
Schols Dominique,
Froeyen Mathy,
Shova SergiuORCID,
De Jonghe Steven,
Macaev Fliur Z.ORCID
Reference53 articles.
1. Abiraterone and novel antiandrogens: overcoming castration resistance in prostate cancer;Ferraldeschi;Annu. Rev. Med.,2013
2. Novel steroidal inhibitors of human cytochrome P45017α (17α-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer;Potter;J. Med. Chem.,1995
3. A-Ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone;Garrido;J. Steroid Biochem. Mol. Biol.,2014
4. Novel D-modified heterocyclic androstane derivatives as potential anticancer agents: Synthesis, characterization, in vitro and in silico studies;Šestić;J. Steroid Biochem. Mol. Biol.,2023
5. Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives;Stevanović;Future Med. Chem.,2024